In Kim on a Whim, Kim St. Onge and guest host Heidi Harris critique public health messaging surrounding Moderna's newly approved mRNA seasonal influenza vaccine targeting adults aged 50 to 64. Kim reviews local news coverage from KMOV and Washington University clinical research studies, contrasting traditional egg-based vaccine efficacy against reported mRNA side-effect rates. Kim shares personal experiences navigating local emergency care facilities following a minor injury involving her young son, while Heidi and Kim examine intake documentation forms and discuss public health communication strategies. Hashtags: #KimOnAWhim #HeidiHarris #mRNAVaccine #Moderna #PublicHealth #LocalNews #KMOV
